Article

Mid-treatment radiologic response as an early predictor of pathologic response in TNBC in the era of pembrolizumab

2026-07-01

Abstract excerpt

<title>Abstract</title> <p> Background Breast MRI is used to monitor neoadjuvant chemotherapy (NAC) response in triple-negative breast cancer (TNBC), yet its predictive value for pathologic complete response (pCR) in the era of carboplatin and pembrolizumab remains incompletely defined. Methods We analyzed 517 TNBC patients who underwent serial MRI (baseline, mid-treatment, post-NAC) across three regimens: non...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c54a2f09-7595-5d25-a27b-13e9fb06b3ca
DOI: 10.21203/rs.3.rs-9947790/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mid-treatment radiologic response as an early predictor of pathologic response in TNBC in the era of pembrolizumabDOI 10.21203/rs.3.rs-9947790/v1Read

Early Identification of Breast Cancer Patients Achieving Radiological Complete Response to NAC: A Clinicopathological and MRI-Based ApproachSemantic proximity Read

BRCA1/2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter AnalysisSemantic proximity Read

Bridging MRI and Oncotype DX: Multimodal Keys to Breast Cancer PrognosisSemantic proximity Read

A clinicopathological-MRI model for predicting pathological complete response after neoadjuvant therapy in breast cancer: a single-center retrospective study with transcriptomic pathway explorationSemantic proximity Read

Magnetic resonance imaging-based radiomics assesses the level of immune cell infiltration in the breast cancer tumor microenvironmentSemantic proximity Read

MRI-based Prognostic Model in Early-Stage HR+/HER2- Breast CancerSemantic proximity Read

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancerSemantic proximity Read

FDG-PET/CT and multimodal machine learning model prediction of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity Read

Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibitionSemantic proximity Read

Radiogenomics Analysis Reveals Tumor Heterogeneity of Triple-Negative Breast CancerSemantic proximity Read

MRI Radiomics and Biological Correlations for Predicting Axillary Lymph Node Burden in Early-Stage Breast CancerSemantic proximity Read

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trialSemantic proximity Read